{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:12:29Z","timestamp":1787868749147,"version":"build-2784847793"},"reference-count":32,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,11,29]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Pulmonary vein isolation (PVI) is an important treatment for atrial fibrillation (AF). However, many patients need more than one procedure to maintain long-term sinus rhythm. Even after two PVIs some may suffer from AF recurrences. We aimed to identify characteristics of patients who fail after two PVI procedures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We included 557 consecutive patients undergoing a first PVI procedure with a second-generation 28\u2009mm cryoballoon. Follow-up procedures were performed using radiofrequency ablation targeting reconnected PVs only. Recurrent AF was defined as any episode of AF lasting &gt;30\u2009s on ECG or 24 hour Holter monitoring performed at 3, 6 and 12 months post procedure. Mean age was 59.1\u00b110.2 years, 383 (68.8%) were male, 448 (80.4%) had paroxysmal AF and the most common underlying condition was hypertension (36.6%). A total of 140\/557 (25.1%) patients underwent redo procedure with PVI only. Of these patients 45 (32.4%) had recurrence of AF. These patients were comparable regarding age and sex to those in sinus rhythm after one or two procedures. Multivariate logistic regression showed that non-paroxysmal AF (OR 1.08 (95% CI 1.01 to 1.15), estimated glomerular filtration rate (OR 0.96, 95%\u2009CI 0.94 to 0.99), bundle branch block (OR 4.17, 95%\u2009CI 1.38 to 12.58), heart failure (OR 4.17, 95%\u2009CI 1.38 to 12.58) and Left Atrium Volume Index (OR 1.04, 95%\u2009CI 1.01 to 1.08) were associated with AF recurrence after two PVIs. The area under the curve for the identified risk factors was 0.74.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Using a PVI-only approach, recurrence of AF after two AF ablation procedures is associated with more advanced underlying disease and persistent types of AF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2021-001718","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T12:09:10Z","timestamp":1640261350000},"page":"e001718","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-3918","authenticated-orcid":false,"given":"Bart A","family":"Mulder","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meelad I H","family":"Al-Jazairi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico T","family":"Magni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessel F","family":"Groenveld","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G","family":"Tieleman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans C P","family":"Wiesfeld","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong E S","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle C","family":"Van Gelder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-070X","authenticated-orcid":false,"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"},{"name":"Thorax Center, Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Blaauw","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"2025081710041529000_8.2.e001718.1","unstructured":"Hindricks G , Potpara T , Dagres N . 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (EACTS). Eur Heart J 2020."},{"key":"2025081710041529000_8.2.e001718.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809033391003"},{"key":"2025081710041529000_8.2.e001718.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408288"},{"key":"2025081710041529000_8.2.e001718.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602014"},{"key":"2025081710041529000_8.2.e001718.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.11.064"},{"key":"2025081710041529000_8.2.e001718.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2003.t01-1-00243.x"},{"key":"2025081710041529000_8.2.e001718.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164989","article-title":"Atrial substrate modification in atrial fibrillation: targeting GP or CfaE? Evidence from meta-analysis of clinical trials","volume":"11","author":"Qin","year":"2016","journal-title":"PLoS One"},{"key":"2025081710041529000_8.2.e001718.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2010.01798.x"},{"key":"2025081710041529000_8.2.e001718.9","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv419"},{"key":"2025081710041529000_8.2.e001718.10","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000771"},{"key":"2025081710041529000_8.2.e001718.11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/clc.23163","article-title":"Pulmonary vein anatomy addressed by computed tomography and relation to success of second-generation cryoballoon ablation in paroxysmal atrial fibrillation","volume":"42","author":"Mulder","year":"2019","journal-title":"Clin Cardiol"},{"key":"2025081710041529000_8.2.e001718.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.07.003"},{"key":"2025081710041529000_8.2.e001718.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-015-0856-x"},{"key":"2025081710041529000_8.2.e001718.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.108.774885"},{"key":"2025081710041529000_8.2.e001718.15","doi-asserted-by":"crossref","first-page":"ii23","DOI":"10.1093\/europace\/euaa418","article-title":"Innovations and paradigm shifts in atrial fibrillation ablation","volume":"23","author":"Mulder","year":"2021","journal-title":"Europace"},{"key":"2025081710041529000_8.2.e001718.16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.hrthm.2017.06.020","article-title":"Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: results from the Cryo-DOSING study (Cryoballoon-ablation dosing based on the assessment of Time-to-Effect and pulmonary vein isolation guidance)","volume":"14","author":"Aryana","year":"2017","journal-title":"Heart Rhythm"},{"key":"2025081710041529000_8.2.e001718.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.019943"},{"key":"2025081710041529000_8.2.e001718.18","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The task force for the management of atrial fibrillation of the european society of cardiology (ESC)developed with the special contribution of the european heart rhythm association (EHRA) of the ESCEndorsed by the european stroke organisation (ESO)","volume":"2016","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2025081710041529000_8.2.e001718.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw285"},{"key":"2025081710041529000_8.2.e001718.20","doi-asserted-by":"crossref","first-page":"f419","DOI":"10.1093\/europace\/eux376","article-title":"Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the 'CLOSE'-protocol","volume":"20","author":"Phlips","year":"2018","journal-title":"Europace"},{"key":"2025081710041529000_8.2.e001718.21","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eul077"},{"key":"2025081710041529000_8.2.e001718.22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jjcc.2019.02.015","article-title":"Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: clinical outcomes from 1STOP, a multicenter observational project","volume":"74","author":"Perego","year":"2019","journal-title":"J Cardiol"},{"key":"2025081710041529000_8.2.e001718.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2018.11.020"},{"key":"2025081710041529000_8.2.e001718.24","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2020.16195","article-title":"Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the Venus randomized clinical trial","volume":"324","author":"Valderr\u00e1bano","year":"2020","journal-title":"JAMA"},{"key":"2025081710041529000_8.2.e001718.25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005405","article-title":"STABLE-SR (electrophysiological substrate ablation in the left atrium during sinus rhythm) for the treatment of nonparoxysmal atrial fibrillation: a prospective, multicenter randomized clinical trial","volume":"10","author":"Yang","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025081710041529000_8.2.e001718.26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15420\/aer.2018.18.2","article-title":"Risk factor management in atrial fibrillation","volume":"7","author":"Brandes","year":"2018","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2025081710041529000_8.2.e001718.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707855"},{"key":"2025081710041529000_8.2.e001718.28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12471-019-1228-3","article-title":"Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation","volume":"27","author":"Al-Jazairi","year":"2019","journal-title":"Neth Heart J"},{"key":"2025081710041529000_8.2.e001718.29","doi-asserted-by":"crossref","first-page":"i26","DOI":"10.1093\/ejcts\/ezy117","article-title":"Three-year follow-up of hybrid ablation for atrial fibrillation","volume":"53","author":"Maesen","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025081710041529000_8.2.e001718.30","article-title":"Update on management of atrial fibrillation in heart failure: a focus on ablation","author":"Mulder","year":"2021","journal-title":"Heart"},{"key":"2025081710041529000_8.2.e001718.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2011.04.012"},{"key":"2025081710041529000_8.2.e001718.32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.004549"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2021-001718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:04:25Z","timestamp":1755450265000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2021-001718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,23]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/openhrt-2021-001718"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2021-001718","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}